naturopathydigest.com -- Inside the Profession

buy microsoft office enterprise 2007

buy Microsoft Office 2003 Professional sp3buy autodesk autocad 2009

Inside the Profession

CCNM Partners With Newman Breastfeeding Clinic

The Canadian College of Naturopathic Medicine (CCNM) recently announced that the renowned Newman Breastfeeding Clinic and Institute has relocated to the Robert Shad Naturopathic Clinic.

The clinic is named for its founder, pediatrician Jack Newman, MD, FRCPC, who started the first hospital-based breastfeeding clinic in Canada in 1984.
Nick De Groot, ND, dean of clinical education, expressed his support for the new clinic and its partnership with CCNM: "The Newman Breastfeeding Clinic and Institute both embodies the principles and practice of naturopathic medicine and provides a wonderful opportunity for our interns to learn from world-renowned experts. This partnership allows future naturopathic doctors to play a leading role in this critical area of mother and infant health care."
For more information about CCNM's Robert Shad Naturopathic Clinic and the Newman Breastfeeding Clinic and Institute, visit www.rsnc.ca.

New Facility, Location for Bastyr Teaching Clinic

On Feb. 22, 2006, the Bastyr University teaching clinic, Bastyr Center for Natural Health, unveiled its new facility at 3670 Stone Way North, just seven blocks south of its previous location. The two-story teaching clinic boasts 32,000 square feet: 22,000 square feet for patient care (including 40 patient care rooms), 2,500 square feet for retail and dispensary use, and 7,500 square feet for administrative space.
Naturopathic medicine, acupuncture, Chinese herbal medicine, nutrition counseling, homeopathy, and physical medicine are among the health care services offered at the clinic. Natural Medicine Team care is located on the second floor with 15 rooms. Physical Medicine Team Care shares space on the second floor with six patient rooms. The first floor houses Acupuncture and Oriental Medicine Team Care in 11 patient rooms. Eight patient rooms are devoted to Practitioner Care.
Project costs for the Bastyr Center exceeded $2 million. The center applied for Leadership in Energy and Environmental Design-Commercial Interiors certification. LEED-CI is the recognized standard for certifying high-performance green interiors that are healthy and productive places to work, less costly to operate and maintain, and reduce the environmental footprint. The clinic features a sustainable cork and marmoleum floor, and an enhanced ventilation ystem that addresses indoor air quality. Adhesives, paint and other materials utilized in the construction of the facility are comprised of low volatile organic compounds (VOCs).
To learn more about the new and improved Bastyr Center for Natural Health teaching clinic, visit www.BastyrCenter.org.

NIH to Study Ability of CoQ₁₀ to Slow Parkinson's Disease

Patients who suffer from the debilitating effects of Parkinson's disease, and the doctors who treat them, might have something to look forward to in the near future. The National Institutes of Health (NIH) is in the process of preparing several major studies on the ability of CoQ₁₀ to slow Parkinson's disease, instead of merely treating its symptoms.
As of press time, the NIH is finalizing plans to enroll hundreds of early-stage Parkinson's patients in a study of extremely high doses of CoQ₁₀. Researchers believe the coenzyme might help to preserve the nerve cells that die off as a consequence of the disease. Parkinson's sufferers are thought to have low levels of CoQ₁₀. In one small study, patients taking extremely high doses showed less impairment over the course of a year than did patients who received a dummy pill or lower doses.
Some Parkinson's patients already take CoQ₁₀ on their own; however, the doses the NIH wants to test are, "drug-like, much higher than over-the-counter doses," said Dr. Story Landis, head of the NIH National Institute of Neurological Disorders and Stroke. The NIH is awaiting Food and Drug Administration approval to begin the clinical trial of CoQ₁₀.
Future NIH-directed studies on treatment options for Parkinson's will evaluate the efficacy of creatine and minocycline, a prescription-only antibiotic administered to reduce inflammation. Preliminary research suggests that creatine and minocycline also might offer a chance at slowing the progression of Parkinson's in some patients.
Written by Kathryn Feather